Earnings per share growth projections for RDAR have been revised upward by 8% for this quarter. RDAR stock forecast models link this to anticipated milestone payments in the biotech pipeline. The RAADR Inc stock holds several negative signals and despite the positive trend, we believe RAADR Incwill perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock . Current score: -2.465 Sell Candidate Unchanged Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage ... Omor Ibne Ehsan is a writer at InvestorPlace. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks. You can follow him on LinkedIn . Short-term traders eye RDAR stock forecast technical breakpoints, with Fibonacci retracement levels suggesting a bullish continuation if $0.80 is breached with high turnover.
